# Canopy Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/canopy-biosciences

- Industry: Biotechnology
- Headquarters: St. Louis, US
- Website: www.canopybiosciences.com
- Total disclosed funding: $2.4M
- Latest round: Series A (May 22, 2018)
- Investors on record: 6

## About

Canopy Biosciences LLC specializes in spatial molecular solutions for life sciences research, focusing on advanced technologies in transcriptomics, proteomics, and genomics.Canopy Biosciences LLC, founded in 2016, is based in St. Louis, US. The company focuses on spatial biology solutions, and was acquired by Bruker Corporation in September 2020. The founder, Crystal Winkeler, has a history of leadership in biotechnology innovations. It has participated in four deals with a most recent funding round being a Series A for USD 2.40 mn, involving investors such as Archangels Investors Limited and Missouri Technology Corporation.Canopy Biosciences LLC provides state-of-the-art spatial molecular solutions, including the CosMx® Spatial Molecular Imager for high-plex single-cell spatial transcriptomics, CellScape™ for spatial proteomics, and GeoMx® Digital Spatial Profiler for whole-tissue spatial multiomics analysis. These technologies cater to research in oncology, immunology, and neuroscience, enabling scientists to explore critical biological questions and improve treatment approaches.The company generates revenue through direct sales and partnerships, adopting a B2B model. Clients purchase advanced instruments and assays like the CosMx® Spatial Molecular Imager and GeoMx® Digital Spatial Profiler either outright or through service agreements, fostering long-term relationships that contribute to revenue growth.Canopy Biosciences LLC aims to expand its offerings by developing new products in spatial biology with plans for launches in the next year. The company is targeting expansion into Europe and Asia-Pacific markets by 2025 to broaden its global reach. The recent funding from their Series A round will support these initiatives, enhancing product development and market entry strategies.

## Funding rounds

- Series A, May 22, 2018, $2.4M — Archangels Investors Limited, BioGenerator, Missouri Technology Corporation, Kingdom Capital, Pinpoint Holdings, LLC, Neon Bloom Inc.

## Investors

- Archangels Investors Limited — Series A
- BioGenerator (https://capitalatlas.ai/funds/biogenerator) — Series A
- Missouri Technology Corporation — Series A
- Kingdom Capital (https://capitalatlas.ai/funds/kingdom-capital) — Series A
- Pinpoint Holdings, LLC — Series A
- Neon Bloom Inc. (https://capitalatlas.ai/funds/neon-bloom-inc) — Series A